Despite the promise of psychedelics for mental health, their social and environmental consequences have received little attention. While psychedelics may foster connection to nature and improve social relationships, positive outcomes are not guaranteed. This commentary on LSD, psilocybin, and MDMA outlines three crucial insights: the importance of setting and rituals, establishing boundaries around use, and understanding the long-term commitment needed to integrate insights. Commercialization threatens to strip away contextual factors. Boundaries on when, how, and with whom psychedelics are used can protect recreational users and align commercial interests with socio-environmental goals. Sustained engagement is required; psychedelics are not a quick fix.
Commercialization of psychedelics, now attracting private sector interest after decades of research hiatus, may reshape their use, goals, and effectiveness. Drawing parallels with the earlier commercialization of mindfulness—which shares spiritual origins and self-transcendent qualities—the article identifies three tensions: separating practices from their spiritual roots, co-optation to reinforce neoliberal principles, and cost-cutting alterations to administration. These tensions arise when well-being practices are implemented in consumer capitalist societies, suggesting that commercialized psychedelics risk similar distortions as seen with mindfulness.